Meda AB - PharmaKB

Meda AB

Meda AB is a specialty pharmaceutical company, headquartered in Solna, Sweden. Meda imports and markets pharmaceuticals, nutritional, and health-care products, and offers services including clinical research, registration, and logistics. At the end of 2014, Meda had 5,202 employees. Meda's pharmaceuticals are currently sold in more than 150 countries.[self-published source]

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Butisol	Butabarbital	1982-01-01		Sleep initiation and maintenance disorders
Reglan	Metoclopramide	2005-06-10	2029-2030	Postoperative nausea and vomiting , Gastroparesis , Gastroesophageal reflux
Rowasa	Mesalamine	1990-12-18	2027-2030	Ulcerative colitis , Proctitis , Sigmoid diseases
Soma	Aspirin, Carisoprodol, Codeine	1983-07-11	2023-2033	Rheumatoid arthritis, Pain, Headache, Fever, Inflammation, Osteoarthritis, Fatigue, Apnea, Rheumatic fever, Gout, Myositis, Muscle cramp, Spasm, Tetanus, Muscle rigidity, Muscle spasticity, Cough, Anxiety disorders, Gastroesophageal reflux, Helicobacter infections, Stomach ulcer, Duodenal ulcer, Zollinger-ellison syndrome, Esophagitis, Heartburn, Postoperative pain, Hypercholesterolemia, Coronary artery disease, Hypertriglyceridemia, Hyperlipoproteinemias, Obstructive lung diseases
Sonata	Zaleplon	1999-03-12		Sleep initiation and maintenance disorders
Thyro-block	Potassium iodide	1982-01-01		—
Zerene	Zaleplon	1999-03-12		Sleep initiation and maintenance disorders